Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.20.2
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2020
Investments All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents As of June 30, 2020, the Company’s cash and cash equivalents balance were as follows: 

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

39,057

 

 

$

 

 

$

39,057

 

 

$

39,057

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

11,024

 

 

 

 

 

 

11,024

 

 

 

11,024

 

Total

 

$

50,081

 

 

$

 

 

$

50,081

 

 

$

50,081

 

 

As of December 31, 2019, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

23,710

 

 

$

 

 

$

23,710

 

 

$

23,710

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

20,355

 

 

 

 

 

 

20,355

 

 

 

20,355

 

Total

 

$

44,065

 

 

$

 

 

$

44,065

 

 

$

44,065

 

Summary of Quantitative Information with Respect to Significant Unobservable Inputs

The following table summarizes quantitative information with respect to the significant unobservable inputs that were used to value the 2020 Stock Warrants during the six months ended June 30, 2020:

 

Compensation Warrant

 

 

Performance Warrant

 

Volatility

 

88

%

 

 

85

%

Risk-free rate

 

0.23

%

 

 

0.34

%

Term

1.7 years

 

 

3.7 years